DE69423427T2 - Transdermales pflaster aus schaumschichtstoff - Google Patents

Transdermales pflaster aus schaumschichtstoff

Info

Publication number
DE69423427T2
DE69423427T2 DE69423427T DE69423427T DE69423427T2 DE 69423427 T2 DE69423427 T2 DE 69423427T2 DE 69423427 T DE69423427 T DE 69423427T DE 69423427 T DE69423427 T DE 69423427T DE 69423427 T2 DE69423427 T2 DE 69423427T2
Authority
DE
Germany
Prior art keywords
foam layer
active agent
disclosed
methods
devices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69423427T
Other languages
English (en)
Other versions
DE69423427D1 (de
Inventor
Alfred Kwiatek
J Weimann
C Pollock
K Govil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Technologies Inc
Original Assignee
Mylan Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mylan Technologies Inc filed Critical Mylan Technologies Inc
Publication of DE69423427D1 publication Critical patent/DE69423427D1/de
Application granted granted Critical
Publication of DE69423427T2 publication Critical patent/DE69423427T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
DE69423427T 1993-05-18 1994-05-18 Transdermales pflaster aus schaumschichtstoff Expired - Fee Related DE69423427T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/063,515 US5503844A (en) 1993-05-18 1993-05-18 Foam laminate transdermal patch
PCT/US1994/005560 WO1994026218A1 (en) 1993-05-18 1994-05-18 Foam laminate transdermal patch

Publications (2)

Publication Number Publication Date
DE69423427D1 DE69423427D1 (de) 2000-04-20
DE69423427T2 true DE69423427T2 (de) 2000-10-19

Family

ID=22049733

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69423427T Expired - Fee Related DE69423427T2 (de) 1993-05-18 1994-05-18 Transdermales pflaster aus schaumschichtstoff

Country Status (8)

Country Link
US (2) US5503844A (de)
EP (1) EP0655900B1 (de)
JP (1) JPH07509258A (de)
AT (1) ATE190481T1 (de)
AU (1) AU6952694A (de)
DE (1) DE69423427T2 (de)
ES (1) ES2144052T3 (de)
WO (1) WO1994026218A1 (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19500662C2 (de) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster und seine Verwendung
US5730721A (en) 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
DE19638570A1 (de) * 1996-09-20 1998-03-26 Bayer Ag Wirkstoffhaltige thermoplastische Polyurethane
US6261405B1 (en) 1997-06-27 2001-07-17 Noven Pharmaceuticals, Inc. Method and apparatus for making a patch
GB9714650D0 (en) * 1997-07-11 1997-09-17 Strakan Ltd Block copolymer
US6143278A (en) * 1998-02-23 2000-11-07 Elkhoury; George F. Topical application of opioid analgesic drugs such as morphine
DE19814257A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
DE19830732B4 (de) * 1998-07-09 2008-11-13 Lts Lohmann Therapie-Systeme Ag Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung
GB9903097D0 (en) * 1999-02-11 1999-03-31 Johnson & Johnson Medical Ltd Poyurethane foams for use in wound dressings
US7063859B1 (en) * 1999-04-28 2006-06-20 Noven Pharmaceuticals, Inc. Barrier film lined backing layer composition and method for topical administration of active agents
US6277401B1 (en) 1999-05-07 2001-08-21 U.S. Dermatologics, Inc. Drug delivery device
DE10032456A1 (de) * 2000-07-04 2002-01-31 Lohmann Therapie Syst Lts Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
KR100382373B1 (ko) * 2000-08-28 2003-05-01 주식회사 동성화학 약제의 역확산 억제능이 우수한 패취제 제조용 폴리우레탄 지지체 및 이의 제조방법
WO2002026484A1 (en) * 2000-09-29 2002-04-04 Trexel, Inc. In-mold decorated articles and methods
DE10063661A1 (de) * 2000-12-20 2002-09-19 Tesa Ag Oberflächenschutzfolie für Lackoberflächen mit einer Selbstklebemasse auf Basis eines Polyurethan-Schaums
DE10136784A1 (de) * 2001-07-27 2003-02-20 Lohmann Therapie Syst Lts Darreichungsformen mit wirkstoffhaltigen Partikeln, zur Anwendung auf der Haut oder Schleimhaut
US7261734B2 (en) * 2002-04-23 2007-08-28 Boston Scientific Scimed, Inc. Resorption-controllable medical implants
EP2561860B1 (de) * 2002-05-31 2018-02-28 Titan Pharmaceuticals, Inc. Implantierbare polymere Vorrichtung zur verzögerten Freisetzung von Buprenorphin
US20040086551A1 (en) * 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
CA2514078C (en) * 2002-12-31 2012-07-10 Ossur Hf Wound dressing
US8524272B2 (en) * 2003-08-15 2013-09-03 Mylan Technologies, Inc. Transdermal patch incorporating active agent migration barrier layer
US7531711B2 (en) * 2003-09-17 2009-05-12 Ossur Hf Wound dressing and method for manufacturing the same
WO2005034797A2 (en) 2003-09-17 2005-04-21 Ossur Hf Wound dressing and method for manufacturing the same
PT1670433E (pt) 2003-10-10 2012-02-08 Ferring Bv Fórmula farmacológica transdérmica para a minimização de resíduos na pele
US20060177487A1 (en) * 2005-02-07 2006-08-10 Christine Martz Moisture and lotion retainer
WO2006055261A2 (en) * 2004-11-05 2006-05-26 Carnegie Mellon University Degradable polyurethane foams
US20060130675A1 (en) * 2004-11-30 2006-06-22 Crawford David S Transdermal nutritional supplement delivery patch
JP3986525B2 (ja) 2004-12-27 2007-10-03 株式会社 アグル 経皮貼り剤及びその製造方法
US7161056B2 (en) * 2005-01-28 2007-01-09 Ossur Hf Wound dressing and method for manufacturing the same
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
US20070065494A1 (en) * 2005-08-03 2007-03-22 Watson Laboratories, Inc. Formulations and Methods for Enhancing the Transdermal Penetration of a Drug
US20070087055A1 (en) * 2005-10-14 2007-04-19 David Jan Directly compressible extended release alprazolam formulation
US20070116749A1 (en) * 2005-11-21 2007-05-24 Grossman Leonard D Method for treatment of cellulitis
US20070118084A1 (en) * 2005-11-21 2007-05-24 Grossman Leonard D Dressing for treatment of cellulitis
JP2009523808A (ja) * 2006-01-20 2009-06-25 モノソル アールエックス リミテッド ライアビリティ カンパニー 活性物質の粘膜投与のためのフィルム包帯
US7749487B2 (en) 2006-03-10 2010-07-06 Conopco, Inc. Method to assess surfactant adsorption on skin
CA2646667C (en) 2006-04-21 2014-03-11 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
US20070259029A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water-dispersible patch containing an active agent for dermal delivery
US7879942B2 (en) * 2006-10-05 2011-02-01 Eastman Chemical Company Switchable adhesive article for attachment to skin and method of using the same
CN101583315A (zh) * 2006-12-12 2009-11-18 比欧帕斯自动化公司 具有可切片弹性多孔材料的活检载具
DE102007006244B4 (de) * 2007-02-08 2012-03-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System zur Verabreichung wasserlöslicher Wirkstoffe
BRPI0807290A2 (pt) * 2007-03-02 2016-10-11 Teika Pharmaceutical Co Ltd "composição medicinal para absorção transdérmica, unidade de armazenamento de composição medicinal e prepraração de absorção transdérmica usando a mesma"
US20090291127A1 (en) * 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
US8329210B2 (en) * 2008-09-23 2012-12-11 Pharmapatch, Llc Twin transdermal drug delivery patch
WO2010034053A1 (en) * 2008-09-26 2010-04-01 Suzana Hillhouse Transdermal delivery device and method
BRPI0917862A2 (pt) * 2008-09-30 2015-11-24 Teikoku Pharma Usa Inc composições transdérmicas de donepezil com distribuição prolongada e métodos para usar as mesmas
WO2010048064A2 (en) * 2008-10-20 2010-04-29 The Brigham And Women's Hospital, Inc. Drug delivery system and its use in the treatment of postherpetic neuralgia
JP2010126449A (ja) * 2008-11-25 2010-06-10 Lintec Corp 経皮吸収貼付剤
JP5396208B2 (ja) * 2009-09-08 2014-01-22 日東電工株式会社 耐水性貼付製剤
DE102009056745A1 (de) * 2009-12-04 2011-06-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung von Peptiden
US20100178307A1 (en) * 2010-01-13 2010-07-15 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
JP5927506B2 (ja) 2010-04-13 2016-06-01 レルマダ セラピューティクス、インク． １−メチル−２’，６’−ピペコロキシリダイドの皮膚医薬組成物および使用方法
US9517164B2 (en) 2010-09-30 2016-12-13 Covidien Lp Wound dressing with advanced fluid handling
EP2583645A1 (de) * 2011-10-21 2013-04-24 Josek Berek Apolet Hautverletzungsschutzvorrichtung
EP2907502A1 (de) * 2014-02-17 2015-08-19 Ferrari S.r.l. Schnittstellenmembran für Kontakt mit der Haut
CA2941446C (en) * 2014-03-06 2022-09-06 Teikoku Seiyaku Co., Ltd. Patch preparation comprising layered support
US10897978B2 (en) 2014-10-21 2021-01-26 The Procter & Gamble Company Method of improving skin appearance
US11702523B2 (en) 2015-09-09 2023-07-18 Bloom Holdings, Llc Algae-derived flexible foam, and method of manufacturing the same
US9872816B2 (en) * 2015-10-22 2018-01-23 The Procter & Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
WO2017070077A1 (en) 2015-10-22 2017-04-27 The Procter & Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
US10576023B2 (en) * 2015-10-22 2020-03-03 The Procter & Gamble Company Barrier patch of a foamed film and methods of improving skin appearance
WO2017087895A1 (en) 2015-11-19 2017-05-26 Bloom Holdings, Llc Algae-derived flexible foam, and a method of manufacturing the same
FI127620B (fi) * 2016-07-12 2018-10-31 Tarmo Pekkarinen Nuuskantyyppinen nikotiini-pellavansiemenrouhekoostumus
EP3565642A1 (de) 2017-01-09 2019-11-13 The Procter and Gamble Company Barrierepflaster mit löslicher folie und verfahren zur verbesserung des hautbildes
US10857076B2 (en) 2017-01-09 2020-12-08 The Procter & Gamble Company Barrier patch with soluble film and methods of improving skin appearance
US10751265B2 (en) 2017-01-09 2020-08-25 The Procter & Gamble Barrier patch with soluble film and methods of improving skin appearance
WO2018237214A1 (en) 2017-06-22 2018-12-27 The Procter & Gamble Company BEAUTY MASK FILMS COMPRISING A WATER SOLUBLE LAYER AND A VACUUM EVAPORATED COATING
WO2019183010A1 (en) 2018-03-19 2019-09-26 The Procter & Gamble Company Method of making a barrier patch with soluble film
WO2021138710A1 (en) * 2020-01-09 2021-07-15 Sg Ventures Pty Limited Substrate for use in a transdermal patch or dressing

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4597961A (en) * 1985-01-23 1986-07-01 Etscorn Frank T Transcutaneous application of nicotine
US5016652A (en) * 1985-04-25 1991-05-21 The Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4710191A (en) * 1985-12-16 1987-12-01 Jonergin, Inc. Therapeutic device for the administration of medicaments
US4627429A (en) * 1986-02-28 1986-12-09 American Home Products Corporation Storage-stable transdermal adhesive patch
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
US4820525A (en) * 1987-09-17 1989-04-11 American Home Products Corporation (Del.) Transdermal drug delivery system
US4839174A (en) * 1987-10-05 1989-06-13 Pharmetrix Corporation Novel transdermal nicotine patch
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
EP1120112A3 (de) * 1990-06-14 2001-11-14 Integra LifeSciences Corporation Wundverband und Vorrichtung zur Verabreichung von Medikamenten

Also Published As

Publication number Publication date
WO1994026218A1 (en) 1994-11-24
DE69423427D1 (de) 2000-04-20
ATE190481T1 (de) 2000-04-15
US5503844A (en) 1996-04-02
EP0655900A1 (de) 1995-06-07
AU6952694A (en) 1994-12-12
EP0655900B1 (de) 2000-03-15
EP0655900A4 (de) 1996-06-12
US5629014A (en) 1997-05-13
ES2144052T3 (es) 2000-06-01
JPH07509258A (ja) 1995-10-12

Similar Documents

Publication Publication Date Title
ATE190481T1 (de) Transdermales pflaster aus schaumschichtstoff
DK0474735T3 (da) Trykfølsomt klæbemiddellaminat
AU7253501A (en) Transdermal therapeutic system for highly dispersed silicon dioxide
DK0716620T3 (da) Reservoir,som kan imprægneres med en opløsning af aktivt stof, til en ionoforetisk anordning til transdermal indgivelse af medicin, og fremgangsmåde til fremstilling af et sådant reservoir
NZ225773A (en) Adhesive dressing containing pharmaceutically active ingredient; processes for preparation
EP0387751A3 (de) Arzneimittel enthaltendes Heftpflaster
LU88849I2 (fr) Climara
IL92924A0 (en) Superficial therapeutic system comprising an antineoplastic active substance
WO2001091718A3 (de) Okklusives transdermales therapeutisches system mit nicht-okklusiver rückschicht
WO1994025025A3 (de) Systeme zur kontrollierten abgabe von pilocarpin
NO993855L (no) Töyelig transdermalt terapeutisk system
AU2001230193A1 (en) Transdermal therapeutic system for the administration of zaleplon
CA2144441A1 (en) Dexpanthenol-containing plaster for the transdermal application of steroid hormones

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: ANWALTSKANZLEI GULDE HENGELHAUPT ZIEBIG & SCHNEIDE

8339 Ceased/non-payment of the annual fee